Details of the Drug Reposition

General Information of This Drug (ID: DM7F2VG)

Drug Name
SA-237   DM7F2VG
Synonyms Second generation IL-6 antagonist (mAb, inflammatory disease), Chugai

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Neuromyelitis optica DISBFGKL 8A43 Phase 3 [1]
Encephalopathy DISRGC2W 8E47 Phase 3 [2]
Rheumatoid arthritis DISTSB4J FA20 Phase 3 [3]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 ClinicalTrials.gov (NCT02073279) Efficacy and Safety Study as Monotherapy of SA237 to Treat NMO and NMOSD. U.S. National Institutes of Health.